Neuberger Berman Group LLC Has $672.19 Million Stock Holdings in Danaher Co. (NYSE:DHR)

Neuberger Berman Group LLC lowered its position in Danaher Co. (NYSE:DHR - Free Report) by 7.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,928,333 shares of the conglomerate's stock after selling 234,073 shares during the quarter. Danaher makes up about 0.5% of Neuberger Berman Group LLC's holdings, making the stock its 26th biggest holding. Neuberger Berman Group LLC owned about 0.41% of Danaher worth $672,194,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Heck Capital Advisors LLC purchased a new stake in shares of Danaher in the 4th quarter valued at about $27,000. Decker Retirement Planning Inc. purchased a new stake in Danaher in the fourth quarter valued at approximately $31,000. Golden State Wealth Management LLC purchased a new position in shares of Danaher during the fourth quarter worth approximately $31,000. Hurley Capital LLC acquired a new position in shares of Danaher in the 4th quarter valued at $34,000. Finally, Pineridge Advisors LLC raised its position in Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock valued at $34,000 after purchasing an additional 57 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Stock Performance

Shares of NYSE:DHR traded up $7.99 during trading hours on Friday, hitting $188.75. The stock had a trading volume of 4,764,014 shares, compared to its average volume of 3,316,814. The stock's fifty day simple moving average is $203.71 and its 200 day simple moving average is $229.91. The firm has a market capitalization of $134.90 billion, a price-to-earnings ratio of 35.75, a PEG ratio of 2.66 and a beta of 0.86. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 1-year low of $171.00 and a 1-year high of $281.70.

Remove Ads

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the business earned $2.09 earnings per share. Sell-side analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.32 dividend. This is a positive change from Danaher's previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date is Friday, March 28th. Danaher's dividend payout ratio is currently 24.24%.

Analyst Ratings Changes

DHR has been the topic of a number of recent research reports. Bank of America upgraded shares of Danaher from a "neutral" rating to a "buy" rating and set a $290.00 price objective on the stock in a research note on Friday, December 13th. Jefferies Financial Group dropped their target price on Danaher from $285.00 to $260.00 and set a "buy" rating on the stock in a report on Wednesday, January 29th. StockNews.com downgraded Danaher from a "buy" rating to a "hold" rating in a report on Saturday, December 14th. Royal Bank of Canada reissued an "outperform" rating and issued a $277.00 price objective (down from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Finally, Robert W. Baird reduced their target price on shares of Danaher from $277.00 to $268.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Four investment analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $276.57.

Insider Activity at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company's stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company's stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 11.10% of the company's stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.